Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer

Clinical trial NCT03750396 · UNKNOWN

Trial details

NCT number: NCT03750396
Sponsor: Gangnam Severance Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Recurrent Breast Cancer Stereotactic Body Radiotherapy Estrogen Receptor Positive Tumor Her2-negative Tumor Surgery

Start date: 2018-08-01
Primary completion: 2021-07-31
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.